Literature DB >> 18456104

Peanut allergy.

A Wesley Burks1.   

Abstract

Peanut allergy has become a major health concern worldwide, especially in developed countries. However, the reasons for this increasing prevalence over the past several decades are not well understood. Because of the potentially severe health consequences of peanut allergy, those suspected of having had an allergic reaction to peanuts deserve a thorough evaluation. All patients with peanut allergy should be given an emergency management plan, as well as epinephrine and antihistamines to have on hand at all times. Patients and families should be taught to recognise early allergic reactions to peanuts and how to implement appropriate peanut-avoidance strategies. It is imperative that severe, or potentially severe, reactions be treated promptly with intramuscular epinephrine and oral antihistamines. Patients who have had such a reaction should be kept under observation in a hospital emergency department or equivalent for up to 4 h because of the possible development of the late-phase allergic response. This Seminar looks at the changing epidemiology of this allergy--and theories as to the rise in prevalence, diagnosis, and management of the allergy, and potential new treatments and prevention strategies under development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456104     DOI: 10.1016/S0140-6736(08)60659-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  52 in total

Review 1.  Evolution of Immune Responses in Food Immunotherapy.

Authors:  Johanna M Smeekens; Michael D Kulis
Journal:  Immunol Allergy Clin North Am       Date:  2019-11-06       Impact factor: 3.479

2.  The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.

Authors:  M Kulis; X Chen; J Lew; Q Wang; O P Patel; Y Zhuang; K S Murray; M W Duncan; H S Porterfield; A W Burks; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2012-02       Impact factor: 5.018

3.  Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy.

Authors:  Yael Gernez; Rabindra Tirouvanziam; Grace Yu; Eliver E B Ghosn; Neha Reshamwala; Tammie Nguyen; Mindy Tsai; Stephen J Galli; Leonard A Herzenberg; Leonore A Herzenberg; Kari C Nadeau
Journal:  Int Arch Allergy Immunol       Date:  2010-10-25       Impact factor: 2.749

4.  IgE-mediated allergen gene vaccine platform targeting human antigen-presenting cells through the high-affinity IgE receptor.

Authors:  Anne Behnecke; Wei Li; Ling Chen; Andrew Saxon; Ke Zhang
Journal:  J Allergy Clin Immunol       Date:  2009-05-07       Impact factor: 10.793

5.  Parsing the peanut panic: the social life of a contested food allergy epidemic.

Authors:  Miranda R Waggoner
Journal:  Soc Sci Med       Date:  2013-05-06       Impact factor: 4.634

6.  Enteric reovirus infection stimulates peanut-specific IgG2a responses in a mouse food allergy model.

Authors:  Ronald J Fecek; Marisa Marcondes Rezende; Ryan Busch; Ine Hassing; Raymond Pieters; Christopher F Cuff
Journal:  Immunobiology       Date:  2010-03-04       Impact factor: 3.144

7.  A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

Authors:  Lynda C Schneider; Rima Rachid; Jennifer LeBovidge; Emily Blood; Mudita Mittal; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2013-10-28       Impact factor: 10.793

8.  A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay.

Authors:  Jing Lin; Francesca M Bruni; Zhiyan Fu; Jennifer Maloney; Ludmilla Bardina; Attilio L Boner; Gustavo Gimenez; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2012-03-23       Impact factor: 10.793

9.  Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.

Authors:  Mike Kulis; Balachandra Gorentla; A Wesley Burks; Xiao-Ping Zhong
Journal:  Mol Nutr Food Res       Date:  2013-02-05       Impact factor: 5.914

10.  Are plasma IL-10 levels a useful marker of human clinical tolerance in peanut allergy?

Authors:  Larisa C Lotoski; F Estelle R Simons; Rishma Chooniedass; Joel Liem; Isha Ostopowich; Allan B Becker; Kent T HayGlass
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.